Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03517449 |
|---|---|
| Brief Title: | Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) |
| First Submitted : | April 25, 2018 |
| First Submitted that Met QC Criteria : | April 25, 2018 |
| First Posted : | May 7, 2018 |
| Results First Submitted : | October 19, 2021 |
| Results First Submitted that Met QC Criteria : | October 19, 2021 |
| Results First Posted : | November 17, 2021 |
| Last Update Submitted that Met QC Criteria : | October 17, 2023 |
| Last Update Posted : | October 18, 2023 |